Skip to main content
Top
Published in: Endocrine 2/2019

01-05-2019 | Original Article

Increased waist-to-hip ratio is associated with decreased urine glucose excretion in adults with no history of diabetes

Authors: Juan Chen, Shanhu Qiu, Haijian Guo, Wei Li, Zilin Sun

Published in: Endocrine | Issue 2/2019

Login to get access

Abstract

Purpose

Promoting urine glucose excretion (UGE) is an attractive approach for the treatment of diabetes. Obesity is associated with increased risk for type 2 diabetes. This study was aimed to investigate the association of waist-to-hip ratio (WHR), a simple measure of abdominal obesity, with UGE determined in subjects without previous history of diabetes.

Methods

We studied the correlation of WHR with UGE in 7485 participants without previous history of diabetes. All participants were given a standard 75 g glucose solution. Clinical parameters and demographic characteristics were assessed. Multiple linear regression analysis and multivariate logistic regression analysis were performed to determine the association of WHR with UGE.

Results

Individuals with high WHR (H-WHR) exhibited significantly lower UGE compared to those with low WHR (L-WHR), in either normal glucose tolerance group or pre-diabetes group. In newly diagnosed diabetes group, individuals with H-WHR also showed lower UGE than those with L-WHR; however, no statistical significance was observed. After adjustment for potential confounding factors, including age, genders, and blood glucose level, WHR was negatively associated with UGE (β = −250.901, 95% CI: −471.891 to −29.911, p = 0.026). However, no significant association was observed between BMI and UGE. Furthermore, multivariable logistic regression model showed that individuals with H-WHR were more likely to have low UGE (OR = 0.83, 95% CI: 0.71–0.97, p = 0.018).

Conclusions

Individuals with H-WHR were at risk for decreased UGE. This study suggests that WHR, but not BMI, might be an important determinant of UGE.
Literature
1.
go back to reference J.E. Gerich, Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet. Med. 27, 136–142 (2010)CrossRefPubMedPubMedCentral J.E. Gerich, Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet. Med. 27, 136–142 (2010)CrossRefPubMedPubMedCentral
2.
go back to reference R.A. DeFronzo, J.A. Davidson, P.S. Del, The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes. Metab. 14, 5–14 (2012)CrossRefPubMed R.A. DeFronzo, J.A. Davidson, P.S. Del, The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes. Metab. 14, 5–14 (2012)CrossRefPubMed
3.
go back to reference R.A. DeFronzo, M. Hompesch, S. Kasichayanula, X. Liu, Y. Hong, M. Pfister, L.A. Morrow, B.R. Leslie, D.W. Boulton, A. Ching, F.P. LaCreta, S.C. Griffen, Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care 36, 3169–3176 (2013)CrossRefPubMedPubMedCentral R.A. DeFronzo, M. Hompesch, S. Kasichayanula, X. Liu, Y. Hong, M. Pfister, L.A. Morrow, B.R. Leslie, D.W. Boulton, A. Ching, F.P. LaCreta, S.C. Griffen, Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes. Diabetes Care 36, 3169–3176 (2013)CrossRefPubMedPubMedCentral
4.
go back to reference A. Osaki, S. Okada, T. Saito, E. Yamada, K. Ono, Y. Niijima, H. Hoshi, M. Yamada, Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy. J. Diabetes Investig. 7, 751–754 (2016)CrossRefPubMedPubMedCentral A. Osaki, S. Okada, T. Saito, E. Yamada, K. Ono, Y. Niijima, H. Hoshi, M. Yamada, Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy. J. Diabetes Investig. 7, 751–754 (2016)CrossRefPubMedPubMedCentral
5.
go back to reference J.P. Wilding, The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metab. Clin. Exp. 63, 1228–1237 (2014)CrossRefPubMed J.P. Wilding, The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metab. Clin. Exp. 63, 1228–1237 (2014)CrossRefPubMed
6.
go back to reference E. Ferrannini, Sodium-glucose co-transporters and their inhibition: clinical physiology. Cell Metab. 26, 27–38 (2017)CrossRefPubMed E. Ferrannini, Sodium-glucose co-transporters and their inhibition: clinical physiology. Cell Metab. 26, 27–38 (2017)CrossRefPubMed
8.
go back to reference J. Lu, R.F. Bu, Z.L. Sun, Q.S. Lu, H. Jin, Y. Wang, S.H. Wang, L. Li, Z.L. Xie, B.Q. Yang, Comparable efficacy of self-monitoring of quantitative urine glucose with self-monitoring of blood glucose on glycaemic control in non-insulin-treated type 2 diabetes. Diabetes Res. Clin. Pract. 93, 179–186 (2011)CrossRefPubMed J. Lu, R.F. Bu, Z.L. Sun, Q.S. Lu, H. Jin, Y. Wang, S.H. Wang, L. Li, Z.L. Xie, B.Q. Yang, Comparable efficacy of self-monitoring of quantitative urine glucose with self-monitoring of blood glucose on glycaemic control in non-insulin-treated type 2 diabetes. Diabetes Res. Clin. Pract. 93, 179–186 (2011)CrossRefPubMed
9.
go back to reference C.P. Kovesdy, S.L. Furth, C. Zoccali, Obesity and kidney disease: hidden consequences of the epidemic. Afr. J. Prim. Health Care Fam. Med. 9, e1–1e3 (2017)CrossRefPubMed C.P. Kovesdy, S.L. Furth, C. Zoccali, Obesity and kidney disease: hidden consequences of the epidemic. Afr. J. Prim. Health Care Fam. Med. 9, e1–1e3 (2017)CrossRefPubMed
10.
go back to reference A. Misra, L. Khurana, Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int. J. Obes. (Lond.). 35, 167–187 (2011)CrossRef A. Misra, L. Khurana, Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int. J. Obes. (Lond.). 35, 167–187 (2011)CrossRef
12.
go back to reference S.J. Pinto-Sietsma, G. Navis, W.M. Janssen, D. de Zeeuw, R.O. Gans, P.E. de Jong, A central body fat distribution is related to renal function impairment, even in lean subjects. Am. J. Kidney Dis. 41, 733–741 (2003)CrossRefPubMed S.J. Pinto-Sietsma, G. Navis, W.M. Janssen, D. de Zeeuw, R.O. Gans, P.E. de Jong, A central body fat distribution is related to renal function impairment, even in lean subjects. Am. J. Kidney Dis. 41, 733–741 (2003)CrossRefPubMed
13.
14.
go back to reference X.D. Yue, J.Y. Wang, X.R. Zhang, J.H. Yang, C.Y. Shan, M.Y. Zheng, H.Z. Ren, Y. Zhang, S.H. Yang, Z.H. Guo, B. Chang, B.C. Chang, Characteristics and impact factors of renal threshold for glucose excretion in patients with type 2 diabetes mellitus. J. Korean Med. Sci. 32, 621–627 (2017)CrossRefPubMedPubMedCentral X.D. Yue, J.Y. Wang, X.R. Zhang, J.H. Yang, C.Y. Shan, M.Y. Zheng, H.Z. Ren, Y. Zhang, S.H. Yang, Z.H. Guo, B. Chang, B.C. Chang, Characteristics and impact factors of renal threshold for glucose excretion in patients with type 2 diabetes mellitus. J. Korean Med. Sci. 32, 621–627 (2017)CrossRefPubMedPubMedCentral
15.
go back to reference S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford, C.C. Lang, Z. Rumboldt, C.L. Onen, L. Lisheng, S. Tanomsup, P. Wangai, F. Razak, A.M. Sharma, S.S. Anand, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005)CrossRef S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford, C.C. Lang, Z. Rumboldt, C.L. Onen, L. Lisheng, S. Tanomsup, P. Wangai, F. Razak, A.M. Sharma, S.S. Anand, Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005)CrossRef
16.
go back to reference J.P. Reis, C.A. Macera, M.R. Araneta, S.P. Lindsay, S.J. Marshall, D.L. Wingard, Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring) 17, 1232–1239 (2009) J.P. Reis, C.A. Macera, M.R. Araneta, S.P. Lindsay, S.J. Marshall, D.L. Wingard, Comparison of overall obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring) 17, 1232–1239 (2009)
17.
go back to reference J. Chen, H.J. Guo, S.H. Qiu, W. Li, X.H. Wang, M. Cai, B. Wang, X.N. Li, Z.L. Sun, Identification of newly diagnosed diabetes and prediabetes using fasting plasma glucose and urinary glucose in a Chinese population: a multicenter cross-sectional study. Chin. Med. J. 131, 1652–1657 (2018)CrossRefPubMedPubMedCentral J. Chen, H.J. Guo, S.H. Qiu, W. Li, X.H. Wang, M. Cai, B. Wang, X.N. Li, Z.L. Sun, Identification of newly diagnosed diabetes and prediabetes using fasting plasma glucose and urinary glucose in a Chinese population: a multicenter cross-sectional study. Chin. Med. J. 131, 1652–1657 (2018)CrossRefPubMedPubMedCentral
18.
go back to reference M.A. van Baak, The peripheral sympathetic nervous system in human obesity. Obes. Rev. 2, 3–14 (2001)CrossRefPubMed M.A. van Baak, The peripheral sympathetic nervous system in human obesity. Obes. Rev. 2, 3–14 (2001)CrossRefPubMed
19.
go back to reference R.H. Elliott, V.B. Matthews, C. Rudnicka, M.P. Schlaich, Is it time to think about the sodium glucose co-transporter 2 sympathetically? Nephrology (Carlton) 21, 286–294 (2016)CrossRef R.H. Elliott, V.B. Matthews, C. Rudnicka, M.P. Schlaich, Is it time to think about the sodium glucose co-transporter 2 sympathetically? Nephrology (Carlton) 21, 286–294 (2016)CrossRef
20.
go back to reference W. Ji, M. Zhao, M. Wang, W. Yan, Y. Liu, S. Ren, J. Lu, B. Wang, L. Chen, Effects of canagliflozin on weight loss in high-fat diet-induced obese mice. PLoS One 12, e0179960 (2017)CrossRefPubMedPubMedCentral W. Ji, M. Zhao, M. Wang, W. Yan, Y. Liu, S. Ren, J. Lu, B. Wang, L. Chen, Effects of canagliflozin on weight loss in high-fat diet-induced obese mice. PLoS One 12, e0179960 (2017)CrossRefPubMedPubMedCentral
21.
go back to reference S. Fujioka, Y. Matsuzawa, K. Tokunaga, S. Tarui, Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metab. Clin. Exp. 36, 54–59 (1987)CrossRefPubMed S. Fujioka, Y. Matsuzawa, K. Tokunaga, S. Tarui, Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metab. Clin. Exp. 36, 54–59 (1987)CrossRefPubMed
22.
go back to reference S.B. Solerte, M. Fioravanti, S. Severgnini, M. Rondanelli, S. Precerutti, G. Vignati, E. Ferrari, Hyperinsulinemia and glucagon serum concentrations influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S122–S123 (2000)CrossRefPubMed S.B. Solerte, M. Fioravanti, S. Severgnini, M. Rondanelli, S. Precerutti, G. Vignati, E. Ferrari, Hyperinsulinemia and glucagon serum concentrations influence renal hemodynamics and urinary protein loss in normotensive patients with central obesity. Int. J. Obes. Relat. Metab. Disord. 24(Suppl 2), S122–S123 (2000)CrossRefPubMed
23.
go back to reference N. Nakamura, T. Matsui, Y. Ishibashi, S. Yamagishi, Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation. Diabetol. Metab. Syndr. 7, 48 (2015)CrossRefPubMedPubMedCentral N. Nakamura, T. Matsui, Y. Ishibashi, S. Yamagishi, Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation. Diabetol. Metab. Syndr. 7, 48 (2015)CrossRefPubMedPubMedCentral
24.
go back to reference J.E. Hall, E.D. Crook, D.W. Jones, M.R. Wofford, P.M. Dubbert, Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324, 127–137 (2002)CrossRefPubMed J.E. Hall, E.D. Crook, D.W. Jones, M.R. Wofford, P.M. Dubbert, Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324, 127–137 (2002)CrossRefPubMed
25.
go back to reference K. Nagai, S. Yoshida, H. Konishi, Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues. Pharmazie 69, 856–859 (2014)PubMed K. Nagai, S. Yoshida, H. Konishi, Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues. Pharmazie 69, 856–859 (2014)PubMed
Metadata
Title
Increased waist-to-hip ratio is associated with decreased urine glucose excretion in adults with no history of diabetes
Authors
Juan Chen
Shanhu Qiu
Haijian Guo
Wei Li
Zilin Sun
Publication date
01-05-2019
Publisher
Springer US
Published in
Endocrine / Issue 2/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1802-2

Other articles of this Issue 2/2019

Endocrine 2/2019 Go to the issue